Pediatrix Medical Group (NYSE:MD – Free Report) had its price objective decreased by Mizuho from $10.00 to $9.00 in a research report released on Wednesday morning, Benzinga reports. Mizuho currently has a neutral rating on the stock. Several other equities research analysts also recently weighed in on the company. Truist Financial reduced their price target […]
Pediatrix Medical Group (NYSE:MD – Free Report) had its price target decreased by Truist Financial from $10.50 to $10.00 in a research note issued to investors on Wednesday, Benzinga reports. Truist Financial currently has a hold rating on the stock. Separately, UBS Group began coverage on shares of Pediatrix Medical Group in a research report […]
Pediatrix Medical Group (NYSE:MD – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02, MarketWatch Earnings reports. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. […]
Pediatrix Medical Group (NYSE:MD – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02, MarketWatch Earnings reports. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. […]
Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2023 Earnings Call Transcript February 20, 2024 Pediatrix Medical Group, Inc. reports earnings inline with expectations. Reported EPS is $0.32 EPS, expectations were $0.32. MD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies […]